COMMUNIQUÉS West-GlobeNewswire

Olympia Pharmaceuticals Adds Gonadorelin to Its Growing Men’s Hormone Portfolio
01/09/2026
A synthetic copy of the hormone signal that prompts the body to make testosterone, the new 1 mg/mL formulation is now available to providers in 49 states for office use ORLANDO, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- [...]
Editas Medicine to Participate in Upcoming Investor Conferences
01/09/2026
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that [...]
Solera Health Adds Noom to Its Weight Management Network, Expanding Digital-First Options for Members
01/09/2026
Partnership brings CDC Full Plus-recognized diabetes prevention program and a no-cost GLP-1 Companion offering to Solera's curated network, in addition to its Noom Weight offering PHOENIX, Sept. 01, 2026 (GLOBE NEWSWIRE [...]
Juniper’s JBS-003 (F-MISO) Program Receives FDA Breakthrough Therapy Designation, Advancing a First-in-Class Hypoxia Tracer Enabling Radiation De-escalation in HPV-Positive Head and Neck Cancer
01/09/2026
BEDMINSTER, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to JBS-003 (18F-fluoromisonidazole, [...]
BiomX Inc. to Become Tessera Defense and Homeland Security Inc.
01/09/2026
Name change effective September 11, 2026; common stock to trade on the NYSE American under the new symbol “HLSQ” NETANYA, Israel, Sept. 01, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the “Company”) today [...]
Inner Voyage Recovery Center earns The Joint Commission's Gold Seal of Approval following unannounced survey
01/09/2026
Woodstock outpatient program maintains national accreditation for behavioral health care after three-year review cycle Woodstock, GA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Inner Voyage Recovery Center, an outpatient [...]
New York Plastic Surgical Group Welcomes Two New Surgeons to Its Team
01/09/2026
Garden City, NY, Sept. 01, 2026 (GLOBE NEWSWIRE) -- New York Plastic Surgical Group (NYPS Group), one of the nation's most respected plastic surgery practices, proudly welcomes two new surgeons, Steven Cai, MD , and Ian [...]
Attelia Expands the International Patient Experience with New Health Tour Mobile App
01/09/2026
The personalised platform brings treatment planning, online consultations, appointments, transfers, real-time support and long-term aftercare into one secure digital journey ANTALYA, Turkiye, Sept. 01, 2026 (GLOBE [...]
Cabaletta Bio to Participate in Upcoming Investor Conferences
01/09/2026
PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically [...]
Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President
01/09/2026
TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI [...]
Elevar Therapeutics to Share Camrelizumab/Rivoceranib Poster at International Liver Cancer Association Conference on Clinical Outcomes in Younger Age Patients with Unresectable Hepatocellular Carcinoma
01/09/2026
In post hoc analysis of CARES-310 trial, combination improved mPFS versus sorafenib across age subgroups Combination also improved mOS versus sorafenib in patients <50 years and ≥50 years Elevar is sponsoring Sept. 3 [...]
MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND
01/09/2026
Positive Toxicology Results From 7-Day Rat and Dog Studies Characterize Tolerability and Inform Dose Selection for Next Phase of IND-Enabling Program, Targeting Q1 2027 IND Submission MIAMI, Sept. 01, 2026 (GLOBE [...]
Scribe Therapeutics to Participate in Upcoming Investor Conferences
01/09/2026
ALAMEDA, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed [...]
Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston
01/09/2026
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced [...]
Recovery Month Shines a Light on Hope, Healing, and the Power of Personalized Care at Futures Recovery Healthcare
01/09/2026
TEQUESTA, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- In recognition of National Recovery Month, Futures Recovery Healthcare is celebrating the resilience of individuals and families affected by substance use and mental [...]
Vor Bio To Participate in Upcoming September Conferences
01/09/2026
BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will participate in the [...]
Eyconis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
01/09/2026
REDWOOD CITY, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Eyconis, Inc., a clinical-stage biotechnology company advancing next-generation, long-acting ophthalmic therapeutics, today announced that members of its [...]
Dianthus Therapeutics to Participate in Three Investor Conferences During September
01/09/2026
NEW YORK and WALTHAM, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
01/09/2026
BRIDGEWATER N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executive Officer, will [...]

Pages